Therapeuticsmd Stock Today
| TXMD Stock | USD 1.90 0.01 0.53% |
Performance0 of 100
| Odds Of DistressOver 82
|
TherapeuticsMD is trading at 1.90 as of the 3rd of May 2024, a 0.53% increase since the beginning of the trading day. The stock's lowest day price was 1.87. TherapeuticsMD has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for TherapeuticsMD are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of February 2024 and ending today, the 3rd of May 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 11th of December 2003 | Category Healthcare | Classification Health Care |
TherapeuticsMD, Inc. operates as a womens healthcare company in the United States. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida. Therapeuticsmd operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. The company has 11.53 M outstanding shares of which 45.91 K shares are at this time shorted by private and institutional investors with about 1.63 trading days to cover. More on TherapeuticsMD
Moving against TherapeuticsMD Stock
| 0.83 | GOOG | Alphabet Class C Aggressive Push | PairCorr |
| 0.72 | AA | Alcoa Corp Financial Report 17th of July 2024 | PairCorr |
| 0.69 | CVX | Chevron Corp Financial Report 26th of July 2024 | PairCorr |
| 0.65 | IMHC | Imperalis Holding Corp | PairCorr |
| 0.64 | XOM | Exxon Mobil Corp Financial Report 26th of July 2024 | PairCorr |
| 0.54 | LRDG | Lord Global Corp | PairCorr |
| 0.49 | AXP | American Express Financial Report 19th of July 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
TherapeuticsMD Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. TherapeuticsMD's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding TherapeuticsMD or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Co-Founder, CEO and Director | Robert Finizio | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation Analysts covering TherapeuticsMD report their recommendations after researching TherapeuticsMD's financial statements, talking to executives and customers, or listening in on TherapeuticsMD's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering TherapeuticsMD. The TherapeuticsMD consensus assessment is calculated by taking the average forecast from all of the analysts covering TherapeuticsMD. | |||||
TherapeuticsMD's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to TherapeuticsMD's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand TherapeuticsMD's financial leverage. It provides some insight into what part of TherapeuticsMD's total assets is financed by creditors.
| |||||
TherapeuticsMD (TXMD) is traded on NASDAQ Exchange in USA. It is located in 951 Yamato Road, Boca Raton, FL, United States, 33431 and employs 1 people. TherapeuticsMD is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 21.85 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate TherapeuticsMD's market, we take the total number of its shares issued and multiply it by TherapeuticsMD's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. TherapeuticsMD conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 11.53 M outstanding shares of which 45.91 K shares are at this time shorted by private and institutional investors with about 1.63 trading days to cover.
TherapeuticsMD currently holds about 27.08 M in cash with (48.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.86, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check TherapeuticsMD Probability Of Bankruptcy
Ownership AllocationTherapeuticsMD maintains a total of 11.53 Million outstanding shares. 30% of TherapeuticsMD outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check TherapeuticsMD Ownership Details
TherapeuticsMD Stock Price Odds Analysis
What are TherapeuticsMD's target price odds to finish over the current price? Based on a normal probability distribution, the odds of TherapeuticsMD jumping above the current price in 90 days from now is more than 94.0%. The TherapeuticsMD probability density function shows the probability of TherapeuticsMD stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days TherapeuticsMD has a beta of 0.4477. This usually implies as returns on the market go up, TherapeuticsMD average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding TherapeuticsMD will be expected to be much smaller as well. Additionally, therapeuticsMD has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of TherapeuticsMD to move above the current price in 90 days from now is more than 94.0 (This TherapeuticsMD probability density function shows the probability of TherapeuticsMD Stock to fall within a particular range of prices over 90 days) .
TherapeuticsMD Stock Institutional Holders
Institutional Holdings refers to the ownership stake in TherapeuticsMD that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of TherapeuticsMD's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing TherapeuticsMD's value.| Instituion | Recorded On | Shares | |
| Ameriprise Financial Inc | 2023-12-31 | 22.5 K | |
| Northern Trust Corp | 2023-12-31 | 16.5 K | |
| J. Goldman & Co Lp | 2023-12-31 | 13.6 K | |
| Dimensional Fund Advisors, Inc. | 2023-12-31 | 10.2 K | |
| Fmr Inc | 2023-12-31 | 8.3 K | |
| Ajovista Llc | 2023-12-31 | 2.2 K | |
| Ubs Group Ag | 2023-12-31 | 1.3 K | |
| Banque Cantonale Vaudoise | 2023-12-31 | 1000 | |
| Bank Of America Corp | 2023-12-31 | 409 | |
| Rubric Capital Management Lp | 2023-12-31 | 1.2 M | |
| Clearline Capital Lp | 2023-12-31 | 466.2 K |
TherapeuticsMD Historical Income Statement
TherapeuticsMD Income Statement is one of the three primary financial statements used for reporting TherapeuticsMD's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of TherapeuticsMD revenue and expense. TherapeuticsMD Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, TherapeuticsMD's Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Total Other Income Expense Net is expected to grow to about 820 K, whereas Total Revenue is forecasted to decline to about 1.2 M. View More FundamentalsTherapeuticsMD Stock Against Markets
Picking the right benchmark for TherapeuticsMD stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in TherapeuticsMD stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for TherapeuticsMD is critical whether you are bullish or bearish towards TherapeuticsMD at a given time. Please also check how TherapeuticsMD's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in TherapeuticsMD without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
| All Next | Launch Module |
TherapeuticsMD Corporate Directors
TherapeuticsMD corporate directors refer to members of a TherapeuticsMD board of directors. The board of directors generally takes responsibility for the TherapeuticsMD's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of TherapeuticsMD's board members must vote for the resolution. The TherapeuticsMD board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Cooper Collins | Independent Director | Profile | |
| David DeLucia | Director, Investor Relations | Profile | |
| Brian Bernick | Chief Clinical Officer, Director | Profile | |
| Robert LaPenta | Independent Director | Profile |
How to buy TherapeuticsMD Stock?
Before investing in TherapeuticsMD, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in TherapeuticsMD. To buy TherapeuticsMD stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of TherapeuticsMD. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase TherapeuticsMD stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located TherapeuticsMD stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased TherapeuticsMD stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as TherapeuticsMD, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy TherapeuticsMD Stock please use our How to Invest in TherapeuticsMD guide.
Already Invested in TherapeuticsMD?
The danger of trading TherapeuticsMD is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of TherapeuticsMD is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than TherapeuticsMD. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile TherapeuticsMD is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether TherapeuticsMD is a strong investment it is important to analyze TherapeuticsMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact TherapeuticsMD's future performance. For an informed investment choice regarding TherapeuticsMD Stock, refer to the following important reports: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TherapeuticsMD. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For information on how to trade TherapeuticsMD Stock refer to our How to Trade TherapeuticsMD Stock guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Complementary Tools for TherapeuticsMD Stock analysis
When running TherapeuticsMD's price analysis, check to measure TherapeuticsMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TherapeuticsMD is operating at the current time. Most of TherapeuticsMD's value examination focuses on studying past and present price action to predict the probability of TherapeuticsMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TherapeuticsMD's price. Additionally, you may evaluate how the addition of TherapeuticsMD to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |
Is TherapeuticsMD's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TherapeuticsMD. If investors know TherapeuticsMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TherapeuticsMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.74) | Revenue Per Share 0.125 | Quarterly Revenue Growth (0.99) | Return On Assets (0.08) | Return On Equity (0.24) |
The market value of TherapeuticsMD is measured differently than its book value, which is the value of TherapeuticsMD that is recorded on the company's balance sheet. Investors also form their own opinion of TherapeuticsMD's value that differs from its market value or its book value, called intrinsic value, which is TherapeuticsMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TherapeuticsMD's market value can be influenced by many factors that don't directly affect TherapeuticsMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TherapeuticsMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if TherapeuticsMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TherapeuticsMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.